Marc Belsky - Net Worth and Insider Trading
Marc Belsky Net Worth
The estimated net worth of Marc Belsky is at least $3 Million dollars as of 2024-11-13. Marc Belsky is the Senior Vice President and CFO of Five Prime Therapeutics Inc and owns about 80,927 shares of Five Prime Therapeutics Inc (FPRX) stock worth over $3 Million. Marc Belsky is also the CFO of Kezar Life Sciences Inc and owns about 1,738 shares of Kezar Life Sciences Inc (KZR) stock worth over $13,018. Details can be seen in Marc Belsky's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Marc Belsky has not made any transactions after 2020-02-04 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Marc Belsky
Marc Belsky Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Marc Belsky owns 2 companies in total, including Kezar Life Sciences Inc (KZR) , and Five Prime Therapeutics Inc (FPRX) .
Click here to see the complete history of Marc Belsky’s form 4 insider trades.
Insider Ownership Summary of Marc Belsky
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| KZR | Kezar Life Sciences Inc | 2020-02-04 | Chief Financial Officer |
| FPRX | Five Prime Therapeutics Inc | 2018-02-26 | Senior Vice President and CFO |
Marc Belsky Latest Holdings Summary
Marc Belsky currently owns a total of 2 stocks. Among these stocks, Marc Belsky owns 80,927 shares of Five Prime Therapeutics Inc (FPRX) as of April 22, 2016, with a value of $3 Million and a weighting of 99.58%. Marc Belsky also owns 1,738 shares of Kezar Life Sciences Inc (KZR) as of February 4, 2020, with a value of $13,018 and a weighting of 0.42%.
Latest Holdings of Marc Belsky
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FPRX | Five Prime Therapeutics Inc | 2016-04-22 | 80,927 | 38.00 | 3,075,226 |
| KZR | Kezar Life Sciences Inc | 2020-02-04 | 1,738 | 7.49 | 13,018 |
Holding Weightings of Marc Belsky
Marc Belsky Form 4 Trading Tracker
According to the SEC Form 4 filings, Marc Belsky has made a total of 0 transactions in Five Prime Therapeutics Inc (FPRX) over the past 5 years. The most-recent trade in Five Prime Therapeutics Inc is the sale of 34,102 shares on April 22, 2016, which brought Marc Belsky around $2 Million.
According to the SEC Form 4 filings, Marc Belsky has made a total of 1 transactions in Kezar Life Sciences Inc (KZR) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kezar Life Sciences Inc is the acquisition of 1,538 shares on February 4, 2020, which cost Marc Belsky around $39,998.
Insider Trading History of Marc Belsky
- 1
Marc Belsky Trading Performance
GuruFocus tracks the stock performance after each of Marc Belsky's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Marc Belsky is 8.95%. GuruFocus also compares Marc Belsky's trading performance to market benchmark return within the same time period. The performance of stocks bought by Marc Belsky within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Marc Belsky's insider trading performs compared to the benchmark.
Performance of Marc Belsky
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.02 | | | | | |
| Relative Return to S&P 500(%) | 0.44 | | | | | |
Marc Belsky Ownership Network
Ownership Network List of Marc Belsky
Ownership Network Relation of Marc Belsky
Marc Belsky Owned Company Details
What does Kezar Life Sciences Inc do?
Who are the key executives at Kezar Life Sciences Inc?
Marc Belsky is the Chief Financial Officer of Kezar Life Sciences Inc. Other key executives at Kezar Life Sciences Inc include 10 percent owner Morningside Venture Investments Ltd , Chief Business Officer Nicholas Michael Mordwinkin , and 10 percent owner Equal Talent Investments Ltd .
Kezar Life Sciences Inc (KZR) Insider Trades Summary
Over the past 18 months, Marc Belsky made no insider transaction in Kezar Life Sciences Inc (KZR). Other recent insider transactions involving Kezar Life Sciences Inc (KZR) include a net sale of 6,688 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of Kezar Life Sciences Inc (KZR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 669 shares of Kezar Life Sciences Inc (KZR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 669 shares.
Kezar Life Sciences Inc (KZR)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kezar Life Sciences Inc Insider Transactions
Marc Belsky Mailing Address
Above is the net worth, insider trading, and ownership report for Marc Belsky. You might contact Marc Belsky via mailing address: C/o Kezar Life Sciences, Inc., 4000 Shoreline Court, Suite 300, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
